Skip to main navigation Skip to search Skip to main content

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

  • Arbeitsgemeinschaft Internistische Onkologie (AIO)
  • , Salah-Eddin Al-Batran
  • , Ralf-Dieter Hofheinz
  • , Alexander Reichart
  • , Claudia Pauligk
  • , Caroline Schönherr
  • , Rudolf Schlag
  • , Gabriele Siegler (Co-author)
  • , Steffen Dörfel
  • , Michael Koenigsmann
  • , Mark-Oliver Zahn
  • , Jörg Schubert
  • , Ali Aldaoud
  • , Heinz-Gert Höffkes
  • , Holger Schulz
  • , Lars Hahn
  • , Jens Uhlig
  • , Wolfgang Blau
  • , Martina Stauch
  • , Jörg Weniger
  • Martin Wolf (Co-author), Lutz Jacobasch, Stephan Bildat, Jürgen Wehmeyer, Nils Homann, Jörg Trojan, Oliver Waidmann, Thomas Fietz, Hans-Peter Feustel, Matthias Groschek, Jan Wierecky, Karin Waibel, Stefan Mahlmann, Uwe Schwindel, Uwe Peters, Gunter Schuch, Daniel Pink, Henning Eschenburg, Marcus-A Wörns, Hans-Detlev Harich, Ludwig Fischer von Weikersthal, Klaus-Ulrich Däßler, Dirk M Behringer, Helmut Messmann, Albrecht Kretzschmar, Eike Gallmeier, Helmut Forstbauer, Volker Kunzmann, Jens Papke, Petra Büchner-Steudel, Ursula Vehling-Kaiser

Research output: Contribution to journalOriginal Articlepeer-review

11 Citations (Web of Science)

Fingerprint

Dive into the research topics of 'Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science